These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26713055)

  • 1. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.
    Ah YM; Lee JY; Choi YJ; Kim B; Choi KH; Kong J; Oh JM; Shin WG; Lee HY
    J Korean Med Sci; 2015 Dec; 30(12):1800-6. PubMed ID: 26713055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions.
    Tu K; Anderson LN; Butt DA; Quan H; Hemmelgarn BR; Campbell NR; McAlister FA;
    Can J Cardiol; 2014 Jun; 30(6):647-52. PubMed ID: 24882536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study.
    Bourgault C; Sénécal M; Brisson M; Marentette MA; Grégoire JP
    J Hum Hypertens; 2005 Aug; 19(8):607-13. PubMed ID: 15920457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.
    Schulz M; Krueger K; Schuessel K; Friedland K; Laufs U; Mueller WE; Ude M
    Int J Cardiol; 2016 Oct; 220():668-76. PubMed ID: 27393848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
    Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
    Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Persistence and adherence: Comparison between the five classes diuretics, beta-blocker, calcium channel blockers, ACE-inhibitors and angiotensin receptor blockers as the first line in antihypertensive therapy].
    Rossol-Haseroth K; Eckes L; Schroeder A
    MMW Fortschr Med; 2011 Mar; 153 Suppl 1():21-5. PubMed ID: 21591327
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States.
    Patel BV; Remigio-Baker RA; Mehta D; Thiebaud P; Frech-Tamas F; Preblick R
    J Clin Hypertens (Greenwich); 2007 Sep; 9(9):692-700. PubMed ID: 17786070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence with antihypertensives in uncomplicated treatment-naïve very elderly patients: a nationwide population-based study.
    Choi KH; Yu YM; Ah YM; Chang MJ; Lee JY
    BMC Cardiovasc Disord; 2017 Aug; 17(1):232. PubMed ID: 28836946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
    Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
    JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study.
    Erkens JA; Panneman MM; Klungel OH; van den Boom G; Prescott MF; Herings RM
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):795-803. PubMed ID: 16178043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: impact of drug class on adherence to antihypertensives.
    Kronish IM; Woodward M; Sergie Z; Ogedegbe G; Falzon L; Mann DM
    Circulation; 2011 Apr; 123(15):1611-21. PubMed ID: 21464050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive Drugs and Diabetic Retinopathy in Patients with Type 2 Diabetes.
    Lin JC; Lai MS
    Ophthalmologica; 2016; 235(2):87-96. PubMed ID: 26695432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of uncomplicated hypertension is associated with a reduction in cardiovascular mortality: a Korean national cohort study.
    Lee CJ; Hwang J; Oh J; Lee SH; Kang SM; Choi D; Kim HC; Park S
    J Hypertens; 2017 May; 35 Suppl 1():S41-S49. PubMed ID: 28350620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients.
    Cho MA; Jeong SY; Sohn I; Kim MS; Kang JH; Paik ES; Lee YY; Choi CH
    Cancer Res Treat; 2020 Apr; 52(2):645-654. PubMed ID: 32019281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
    Simonyi G; Ferenci T; Finta E; Igaz I; Balogh S; Gasparics R; Medvegy M
    Orv Hetil; 2019 Mar; 160(9):343-348. PubMed ID: 30798621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.